China Biotech Services Holdings Limited (8037.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 770.84M |
| Enterprise Value | 1.15B |
| P/E Ratio | -8.81 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 8.23 |
| Price/Book Ratio | 3.16 |
| Enterprise/Revenue | 13.44 |
| Enterprise/EBITDA | -16.56 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.94 |
| Operating Margin | -1.03 |
AD
Management Effectiveness
| Return On Assets | -0.1 |
| Return On Equity | -0.31 |
Income Statement
| Revenue | 73.5M |
| Revenue/Share | 0.08 |
| Gross Profit | 7.73M |
| EBITDA | -59.65M |
| Net Income | -68.78M |
| Diluted EPS | -0.07 |
Balance Sheet
| Total Cash | 12.08M |
| Total Cash/Share | 0.01 |
| Total Debt | 394.9M |
| Total Debt/Equity | 2.06 |
| Current Ratio | 0.23 |
| Book Value Per Share | 0.16 |
Price History
| 52-Week Change | -49.18 |
| 52-Week High | 1.33 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 0.59 |
| Moving Average 200 Days | 0.71 |
Statistics
| Average Volume | 461,507 |
| Shares Outstanding | 975.73M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | February 23, 2016 |
AD
